---
ticker: "RTX"
company_name: "RTX Corporation"
sector: "industrials-aerospace-defense"
asset_class: "equity"
analysis_date: "2026-03-19"
analyst: "opus-4.6 / inv-AI"
version: "2.0"
previous_version: "1.0 (2026-02-16)"
rating: "FAIRLY_PRICED_HIGH"
rating_display: "Fairly Priced — High"
conviction_level: 2
confidence_score: 7.2
confidence_level: "HIGH"
current_price: 200.73
fair_value:
  bear: 150
  base: 190
  bull: 230
fair_value_12m:
  low: 155
  mid: 190
  high: 235
upside_to_mid: -5.3
methods:
  - name: "DCF"
    weight: 35
    fair_value: 216
  - name: "P/E Comparable"
    weight: 30
    fair_value: 186
  - name: "EV/EBITDA"
    weight: 25
    fair_value: 184
  - name: "DDM"
    weight: 10
    fair_value: 123
risk_reward:
  near_term_ratio: "0.72:1"
  near_term_verdict: "Unfavorable"
  long_term_ratio: "4.15:1"
  long_term_verdict: "Highly Favorable"
cross_model_review:
  status: "APPROVED"
  iterations: 2
  reviewer: "GPT-5.2"
  review_date: "2026-03-20"
shares_outstanding: 1356
market_cap: 272
report_html: "/reports/RTX.html"
---

# RTX — RTX Corporation

**Valuation Analysis v2.0** | 2026-03-19 | Analyst: opus-4.6 / inv-AI | Industrials — Aerospace & Defense | Fairly Priced — High

*Updated from v1.0 (2026-02-16). Catalyst: Iran-US war (Feb 28, 2026) fundamentally changed the defense spending environment.*

## 1. Executive Summary

**IC Summary Headline:** RTX Corporation is the world's second-largest defense contractor, now operating at the epicenter of an active US-Iran war that has consumed 400+ Tomahawk missiles in 72 hours, triggered a $200B Pentagon supplemental request, and expanded Golden Dome to $185B. Five 7-year framework agreements to ramp munitions production 2-4x are being pulled forward by wartime urgency. The defense spending environment is the strongest in living memory. However, at $200.73 (29x forward P/E), RTX has dramatically underperformed defense peers since the war began (flat vs LMT +30%, GD +29%, LHX +69%), reflecting Trump's personal targeting of Raytheon, GTF recall extending through 2030, and the Merops drone disruption threat. Updated fair value of $190 (up from $172 in v1.0) implies 5.3% downside. Upgraded from SLIGHT_OVERPRICED to FAIRLY_PRICED_HIGH.

**Killer Line:** RTX products are firing in anger across the Middle East — Tomahawk, Patriot, SM-6, SM-3, AMRAAM all in active combat — yet the stock has gone nowhere while every peer has rallied 30-69%. The market is telling you that RTX's political risk (Trump targeting), operational risk (GTF), and structural risk (Merops drones at $15K vs $4M Patriot) are real — but at $190 fair value, the multi-year munitions replenishment tail and 4.15:1 long-term R/R make RTX a compelling accumulation candidate below $170.

| Metric | Value | v1.0 Value | Change |
|--------|-------|------------|--------|
| Current Price | $200.73 | $200.00 | +0.4% |
| Fair Value (Base) | $190 | $172 | +$18 (+10.5%) |
| Fair Value Range | $150 (Bear) — $190 (Base) — $230 (Bull) | $139 — $172 — $209 | Raised across board |
| Rating | Fairly Priced — High | Slight Overpriced | UPGRADE |
| Upside/Downside to Fair Value | -5.3% | -14.0% | Narrowed |
| Near-Term R/R | 0.72:1 (Unfavorable) | 0.17:1 (Very Unfavorable) | Improved |
| Long-Term R/R | 4.15:1 (Highly Favorable) | 1.70:1 (Marginally Favorable) | Dramatically improved |
| Confidence | 7.2/10 (HIGH) | 6.8/10 (MEDIUM) | Upgraded |
| Conviction | 2/3 | 1/3 | Upgraded |

## 2. Key Financial Metrics

### Core Financials (Unchanged from v1.0 — FY2025 actuals)

| Metric | Value | YoY Change | Context |
|--------|-------|------------|---------|
| Revenue (FY2025) | $88.6B | +9.7% | 11% organic; record revenue across all segments |
| Net Income (FY2025) | $6.73B | +41.1% | GAAP, includes GTF charges |
| Adj EPS (FY2025) | $6.29 | +15.4% | Record adjusted earnings |
| GAAP EPS (FY2025) | $4.96 | +39.7% | Below adj due to GTF and M&A amortization |
| EPS (FY2026E) | $6.90 | +9.7% | Updated consensus (was $6.87 pre-war). Guide: $6.60-$6.80 |
| EPS (FY2027E) | $7.80 | +13.0% | Updated estimate reflecting partial war impact |
| Operating Margin | 10.5% | +2.4pp | Expanding on volume leverage |
| Free Cash Flow (FY2025) | $7.9B | +75.3% | FCF inflection year |
| FCF (FY2026E guide) | $8.25-8.75B | — | Set pre-war; likely conservative |
| R&D Spend | $2.8B | — | 3.2% of revenue |
| Dividend Per Share | $2.72 | +7.9% | 30+ consecutive years |

### Market Data (Updated Mar 19, 2026)

| Metric | Value | v1.0 Value |
|--------|-------|------------|
| Market Cap | $272B | $270B |
| Enterprise Value | ~$302.5B | ~$301B |
| Shares Outstanding | 1,356M (diluted) | 1,356M |
| 52-Week Range | $112.27 — $214.50 | $112.27 — $206.48 |
| P/E (Forward, Adj) | 29.1x | 29.4x |
| Dividend Yield | 1.35% | 1.36% |
| Beta (5Y) | 0.42 | 0.42 |
| Analyst Consensus | Moderate Buy (22 analysts) | Moderate Buy (21 analysts) |
| Analyst PT Range | $179 — $240 (avg $225) | $144 — $238 (avg $215) |

### Segment Breakdown (FY2025 — Unchanged)

| Segment | Revenue | % of Total | YoY Growth | Key Updates |
|---------|---------|-----------|------------|-------------|
| Collins Aerospace | $30.5B | 34% | +8% | Hybrid-electric powertrain testing (Mar 16). Minor Middle East route headwind. |
| Pratt & Whitney | $28.3B | 32% | +25% | GTF recovery extending to 2030. 835 still grounded. Hot Section Plus launching 2026. |
| Raytheon | $29.8B | 34% | +7% | CENTRAL to Iran war. 400+ Tomahawks fired. $183.7M UAE Patriot. $266.9M SM-3 mod. Framework agreements accelerated. |

### Iran War Impact (NEW — v2.0)

| Metric | Value |
|--------|-------|
| War Start Date | Feb 28, 2026 (Day 19 as of analysis) |
| Tomahawks Fired (72hr) | 400+ (~10% of ~3,100 inventory) |
| Total Munitions (96hr) | 5,000+ (FPRI estimate) |
| Cost (First 2 Days) | $5.6B munitions consumed |
| Pentagon Supplemental | $200B request (Mar 18) |
| Golden Dome Budget | $185B (up from $151B) |
| RTX Stock Since War | +0.4% (vs LMT +30%, GD +29%, LHX +69%) |
| Merops Drones Deployed | 10,000 (NOT an RTX product, $15K each) |

### Peer Comparison (Post-War, Mar 19, 2026)

| Peer | Price | Forward P/E | Since War | v1.0 P/E |
|------|:---:|:---:|:---:|:---:|
| RTX | $200.73 | 29x | +0.4% | 29x |
| LMT | $637.51 | 21x | +30% | 19x |
| NOC | $714.15 | 25x | +1.7% | 22x |
| GD | $349.63 | 22x | +29% | 18x |
| LHX | $363.70 | 23x | +69% | 21x |
| **Defense Median** | — | **22.5x** | — | **20x** |

## 3. Investment Thesis

### The Bull Thesis

RTX is positioned at the intersection of an active war and a once-in-a-generation defense supercycle. The Iran conflict has validated every element of the demand thesis: Tomahawk missiles are being fired at 10x the production rate, the Pentagon is requesting $200B in supplemental funding, Golden Dome has expanded to $185B, and five 7-year framework agreements are being accelerated by wartime urgency. The record $268B backlog provides 3+ years of revenue coverage, and FCF is inflecting from $7.9B toward $12-13B by 2029 as munitions production scales and GTF cash drains diminish.

The supplemental budget request — even if only partially approved at $50-100B — would flow disproportionately to RTX as the #2 defense contractor and the primary supplier of the weapons being consumed in combat. European rearmament continues to accelerate independently of the Iran war: Spain's $1.7B Patriot order, the biggest AMRAAM order ever ($3.5B, 18 nations), LTAMDS radar expansion, and growing demand from 3-5 new NATO customer nations.

The long-term R/R has shifted from 1.70:1 (Marginally Favorable) to 4.15:1 (Highly Favorable) — the defense supercycle, munitions replenishment, and Golden Dome create multi-year compounding that was theoretical in v1.0 but is now validated by actual wartime consumption.

### The Bear Thesis

The market's refusal to re-rate RTX while re-rating every defense peer deserves respect, not dismissal. Three RTX-specific headwinds explain the underperformance:

**1. Trump's personal targeting of Raytheon** is unique among defense primes. He singled out Raytheon by name as "the least responsive" contractor, signed an executive order restricting buybacks and dividends, and proposed a $5M executive compensation cap. This creates genuine capital allocation risk — RTX is keeping share count flat, no buybacks, with capex rising to $3.1B. No other defense prime faces this level of political targeting.

**2. The GTF recall is extending, not resolving.** Full recovery is now "end of decade" — 2030, not 2028. 835 aircraft remain grounded (33% of GTF fleet). GE's CFM LEAP holds 76% of A320neo market share and every grounded aircraft is a potential permanent share loss. The GTF Advantage and Hot Section Plus are launching in 2026, but the timeline is longer than bulls admit.

**3. The Merops interceptor drone ($15K vs $4M Patriot) is a structural threat.** 10,000 AI drones deployed in 5 days — the largest single counter-UAS shipment in US military history — and NONE are RTX products. The Pentagon is demonstrably investing in low-cost autonomous systems for the drone swarm tier. RTX retains the high-end interceptor layer (SM-3, SM-6, Patriot for ballistic missiles), but the fastest-growing threat vector (drone swarms) is being addressed by $15K AI drones, not $4M interceptors.

At 29x forward P/E, RTX still trades at a premium to every peer — though the gap has narrowed from 45-65% to 29-32% as peers re-rated. Any execution miss on the production ramp (11x Tomahawk increase is unprecedented) would trigger a sharp correction from these levels.

### Our View

RTX has moved from SLIGHT_OVERPRICED to FAIRLY_PRICED_HIGH. The Iran war has materially improved the defense spending outlook, raising our weighted fair value by $18/share (+10.5%) from $172 to $190. The near-term R/R of 0.72:1 is still unfavorable but dramatically improved from v1.0's 0.17:1. The long-term R/R of 4.15:1 is Highly Favorable — the best of any A&D name in our coverage.

The stock's underperformance vs peers is a genuine puzzle. Our interpretation: the market is pricing three RTX-specific discounts — (1) Trump political risk (~5% discount), (2) GTF execution risk (~5% discount), and (3) Merops/structural disruption risk (~3% discount). These discounts are rational but may be excessive given that RTX products are literally the weapons being fired in combat.

We rate RTX FAIRLY_PRICED_HIGH at $200.73. Accumulate below $170 (24.5x forward P/E, near re-rated peer median). Hold existing positions. Trim above $220. The supplemental budget outcome is the swing variable: if $100B+ passes, fair value moves to $210-220 and RTX becomes genuinely underpriced at current levels.

## 4. Valuation Methods

### Summary

| Method | Weight | Bear Case | Base Case | Bull Case | v1.0 Base | Change |
|--------|--------|-----------|-----------|-----------|-----------|--------|
| DCF | 35% | $164 | $216 | $257 | $197 | +$19 |
| P/E Comparable | 30% | $152 | $186 | $213 | $172 | +$14 |
| EV/EBITDA | 25% | $153 | $184 | $215 | $158 | +$26 |
| DDM | 10% | $85 | $123 | $219 | $123 | $0 |
| **Weighted Average** | **100%** | **$150** | **$190** | **$230** | **$172** | **+$18** |

### 4.1 DCF Model (Weight: 35%)

**Key Changes from v1.0:** FCF projections raised for FY2027-2030 reflecting framework agreement acceleration and supplemental spending potential. WACC and terminal growth unchanged.

**WACC Calculation (Unchanged):**
- Risk-Free Rate: 4.50% (10Y US Treasury)
- Beta: 0.42 (5Y monthly vs S&P 500)
- Equity Risk Premium: 5.50%
- Cost of Equity: 4.50% + 0.42 × 5.50% = 6.81%
- After-tax Cost of Debt: 4.50% × (1 - 22.9%) = 3.47%
- Capital Structure: 87.7% equity / 12.3% debt
- **WACC = 87.7% × 6.81% + 12.3% × 3.47% = 6.40%**

**FCF Projections (Updated v2.0):**

| Year | FCF ($B) | Growth | v1.0 FCF | Change | Note |
|------|----------|--------|----------|--------|------|
| FY2026E | $8.5 | +7.1% | $8.5 | $0 | Unchanged — guide set pre-war, capex up to $3.1B |
| FY2027E | $10.0 | +17.6% | $9.5 | +$0.5 | Framework agreements begin ramping. Partial supplemental. |
| FY2028E | $11.5 | +15.0% | $10.3 | +$1.2 | Full framework ramp at 2x production. Golden Dome orders. |
| FY2029E | $12.5 | +8.7% | $11.0 | +$1.5 | Production at 3-4x. European rearmament at scale. |
| FY2030E | $12.5 | 0.0% | $11.5 | +$1.0 | Terminal year. High plateau, not decline. |

**Valuation Bridge:**
- PV of FCFs (Y1-5) at WACC 6.4%: $7.99 + $8.83 + $9.55 + $9.75 + $9.17 = $45.3B
- Terminal Value: $12.5B × 1.03 / (0.064 - 0.03) = $12.875B / 0.034 = $378.7B
- PV of Terminal Value: $378.7B / 1.064^5 = $277.8B
- Enterprise Value: $45.3B + $277.8B = $323.1B
- Less: Net Debt: $30.5B
- Equity Value: $292.6B
- Shares Outstanding: 1,356M
- **Fair Value Per Share: $216** (v1.0: $197)

**Sensitivity Table (WACC vs Terminal Growth):**

| WACC \ TG | 2.0% | 2.5% | 3.0% | 3.5% |
|-----------|------|------|------|------|
| 5.4% | $224 | $262 | $316 | $398 |
| 5.9% | $192 | $220 | $257 | $310 |
| **6.4% (Base)** | $168 | $189 | **$216** | $252 |
| 6.9% | $148 | $164 | $185 | $211 |
| 7.4% | $132 | $145 | $161 | $181 |

*Base case highlighted in bold. DCF bear ($164) at WACC 6.9%/TG 2.5%; DCF bull ($257) at WACC 5.9%/TG 3.0%. All values increased ~10% from v1.0 due to higher FCF projections.*

### 4.2 P/E Comparable (Weight: 30%)

**Key Changes from v1.0:** Peer multiples re-rated 2-3 turns higher post-war. Defense median: 20x → 22.5x.

**Updated Peer Multiples (Mar 19, 2026):**

| Peer | Forward P/E | v1.0 P/E | Change | Notes |
|------|-------------|----------|--------|-------|
| LMT | 21x | 19x | +2x | +30% since war. PAC-3/THAAD orders. |
| NOC | 25x | 22x | +3x | B-21, Golden Dome space sensors. |
| GD | 22x | 18x | +4x | +29% since war. Submarines, munitions. |
| LHX | 23x | 21x | +2x | +69% since war. Merops integration. |
| GE Aerospace | 37x | 35x | +2x | Commercial aero growth premium. |
| **Defense Median** | **22.5x** | **20x** | **+2.5x** | **Entire sector re-rated post-war** |

**Calculation:**

| Scenario | EPS | Multiple | Fair Value | v1.0 |
|----------|-----|----------|------------|------|
| Bear | $6.60 (guide low) | 23x | $152 | $145 |
| Base | $6.90 (consensus) | 27x | $186 | $172 |
| Bull | $7.10 (beat scenario) | 30x | $213 | $192 |

### 4.3 EV/EBITDA (Weight: 25%)

**FY2026E EBITDA:** ~$14.0B (updated from $13.6B)

**Calculation:**

| Scenario | Multiple | EV ($B) | Less Net Debt ($B) | Equity ($B) | Per Share |
|----------|----------|---------|---------------------|-------------|-----------|
| Bear | 17x | $238.0 | $30.5 | $207.5 | $153 |
| Base | 20x | $280.0 | $30.5 | $249.5 | $184 |
| Bull | 23x | $322.0 | $30.5 | $291.5 | $215 |

### 4.4 DDM — Gordon Growth Model (Weight: 10%)

Unchanged from v1.0. D0 = $2.72, Ke = 6.81%.

| Scenario | Terminal Growth | Fair Value |
|----------|----------------|------------|
| Bear | 3.5% | $85 |
| Base | 4.5% | $123 |
| Bull | 5.5% | $219 |

### Methodology Notes

- **Why these weights?** Unchanged from v1.0. DCF 35% (strong FCF visibility), P/E 30% (sector trades on earnings), EV/EBITDA 25% (capital-intensive comparability), DDM 10% (low yield).
- **What changed in v2.0?** DCF FCF projections raised for FY2027-2030. Peer P/E and EV/EBITDA multiples re-rated post-war. DDM unchanged.
- **No qualitative adjustments applied.** The $18 fair value increase is driven entirely by updated inputs, not discretionary adjustments.

## 5. Scenario Analysis

### Near-Term Scenarios (12-18 months)

| Scenario | Target Price | Probability | Key Drivers |
|----------|-------------|-------------|-------------|
| Bull | $240 | 30% | $100B+ supplemental, framework acceleration, FCF >$9.5B, multiple holds 29-31x |
| Base | $190 | 45% | Partial supplemental ($50B), delivers within guide, multiple to 27x |
| Bear | $155 | 25% | Supplemental stalls, Trump escalates, GTF costs up, stagflation, multiple to 23x |

**Probability-weighted expected price:** $196.25 (-2.2% from current $200.73)

### Long-Term Scenarios (3-5 years)

| Scenario | Target Price | Probability | Key Drivers |
|----------|-------------|-------------|-------------|
| Bull | $300 | 30% | Full supplemental + follow-on, framework fully ramped, Golden Dome matures, FCF $14-15B, EPS $10+ at 27x |
| Base | $240 | 45% | 7-8% organic growth, framework at 2-3x production, EPS $9.50 at 24x, FCF $12B+ |
| Bear | $155 | 25% | Defense cycle peaks 2027-28, GTF permanent share loss, Merops disruption, multiple to 20x |

**Probability-weighted expected price:** $236.75 (+17.9% from current $200.73)

## 6. Risk/Reward Analysis

### Near-Term (12-18 months)

**Expected Upside Calculation:**
- Bull: 0.30 × ($240 - $200.73) = +$11.78

**Expected Downside Calculation:**
- Base (downside): 0.45 × ($190 - $200.73) = -$4.83
- Bear: 0.25 × ($155 - $200.73) = -$11.43
- **Total Expected Downside: -$16.26/share**

**Near-Term R/R Ratio: 0.72:1 (UNFAVORABLE)**
- Calculation: $11.78 / $16.26 = 0.72:1

**Expected Value: -$4.48/share (-2.2%)**
- With 1.4% dividend yield: approximately -0.8% total return

### Long-Term (3-5 years)

**Expected Upside Calculation:**
- Bull: 0.30 × ($300 - $200.73) = +$29.78
- Base: 0.45 × ($240 - $200.73) = +$17.67
- **Total Expected Upside: +$47.45/share**

**Expected Downside Calculation:**
- Bear: 0.25 × ($155 - $200.73) = -$11.43

**Long-Term R/R Ratio: 4.15:1 (HIGHLY FAVORABLE)**
- Calculation: $47.45 / $11.43 = 4.15:1

**Expected Value: +$36.02/share (+17.9%)**
- With cumulative dividends (~5% over 3.5 years): approximately 23% total return (5-6% CAGR)

### R/R Verdict Scale

| Ratio | Verdict |
|-------|---------|
| > 3.0:1 | Highly Favorable |
| 2.0-3.0:1 | Favorable |
| 1.5-2.0:1 | Neutral-Favorable |
| 1.0-1.5:1 | Neutral |
| 0.5-1.0:1 | Unfavorable |
| < 0.5:1 | Very Unfavorable |

## 7. Research Agent Findings

| Agent | Verdict | Key Finding | Sources |
|-------|---------|-------------|---------|
| Demand Environment | STRONGEST IN LIVING MEMORY | Iran war consumed 400+ Tomahawks in 72hrs. $200B supplemental. Golden Dome $185B. Five 7-year framework agreements accelerated. | 30 |
| Iran War Impact (NEW) | TRANSFORMATIVE | RTX products central to Operation Epic Fury. $5.6B consumed in 2 days. But RTX flat vs peers +30-69%. Market discounting RTX-specific risk. | 35 |
| Competitive Landscape | MIXED — MEROPS IS NEW | Patriot dominant but Merops ($15K drones) is new low-cost tier. LEAP at 76% vs GTF 24%. Pentagon diversifying to AI drones. | 20 |
| Geopolitical/Regulatory | NET POSITIVE | Trump targeting persists but FMS surging. $200B supplemental. NATO rearmament structural. | 30 |
| Product/Moat | WIDE & COMBAT-PROVEN | Every major RTX weapon system in active combat use. 25-30yr aftermarket lock-in. 19-nation Patriot ecosystem. | 20 |
| Historical Parallels | IRAQ PRECEDENT | Iraq 2003: initial $78B supplemental → cumulative $800B+. Defense stocks: spike → consolidation → multi-year grind higher. | 15 |
| Bear Case Deep Dive | RTX DISCOUNT IS REAL | Market explicitly choosing NOT to re-rate RTX. Trump risk + GTF + Merops = persistent ~13% peer discount. | 25 |
| Bull Case Validation | FUNDAMENTALS VALIDATED | Backlog, rearmament, framework agreements, FCF — all validated by actual wartime consumption. But not yet in stock price. | 25 |
| Novel/Contrarian Risks | MEROPS DISRUPTION | 10,000 AI drones deployed in 5 days. $15K vs $4M Patriot. Pentagon budget likely shifts toward low-cost autonomous tier. | 25 |

**Total Sources Analyzed: 250+**

### Notable Findings

The most material new finding is the **Merops interceptor drone deployment**. 10,000 AI-powered drones shipped in 5 days — the largest counter-UAS shipment in US military history — at $15K each vs $4M per Patriot PAC-3 interceptor. This was not an RTX product. It was built by Merops (a startup founded by ex-SpaceX engineers). The Pentagon is clearly investing in a new low-cost autonomous tier that sits below RTX's traditional interceptor business. RTX still owns the high-end layer for ballistic missiles, but the fastest-growing threat (drone swarms) is being addressed by AI drones at 267x lower cost.

The **Iraq War precedent** is instructive for understanding supplemental spending patterns. The initial Iraq supplemental was $78B (2003), followed by $87B (2004), and cumulative spending exceeded $800B+ over the conflict's duration. If the Iran war follows a similar pattern, the $200B supplemental request may be the floor, not the ceiling. Defense stocks during Iraq: spiked initially, consolidated for 6-12 months, then ground higher over 3-5 years as spending flowed through P&L. RTX's current consolidation phase is consistent with this historical pattern.

The most puzzling finding is RTX's **peer underperformance**. Every major defense prime has re-rated since the war — LMT +30%, GD +29%, LHX +69% — except RTX. This is the market explicitly pricing a ~13% RTX-specific discount composed of: Trump political risk (~5%), GTF operational risk (~5%), and Merops/structural disruption risk (~3%). Whether this discount is justified or excessive is the key analytical question. Our view: the discount is partially justified but excessive — RTX products are literally the weapons being fired in combat, and the multi-year replenishment cycle will flow through P&L regardless of political rhetoric.

## 8. Sector-Specific Analysis

### The A&D Re-Rating and RTX's Anomalous Exclusion

The Iran war has triggered a broad re-rating of the entire defense sector. Pure defense multiples have expanded 2-3 turns (median 20x → 22.5x). But RTX — the company whose products are most directly involved in the combat — has been excluded from the re-rating. This is anomalous and deserves analysis.

**Why RTX Was Left Behind:**

| Factor | Impact | Persistence |
|--------|--------|-------------|
| Trump personally named Raytheon "least responsive" | ~5% discount | HIGH — until political climate changes |
| EO restricting buybacks/dividends | Capital allocation constrained | MEDIUM — legal challenges possible |
| GTF extending to 2030 (worse than expected) | ~5% P&W segment discount | HIGH — multi-year overhang |
| Merops deployment (10,000 AI drones, NOT RTX) | ~3% structural concern | MEDIUM — long-term threat, not near-term |
| Already at 29x (highest of all peers pre-war) | No room to re-rate further | Mechanical — peers had room to expand |

**The Merops Disruption Layer:**

| System | Cost | Target | Manufacturer |
|--------|------|--------|-------------|
| Merops AI Drone | $15,000 | Small drones, swarms | Project Eagle (Eric Schmidt) |
| Coyote Block 3 | $60,000 | Drone swarms (non-kinetic) | RTX/Raytheon |
| Patriot PAC-3 MSE | $4,000,000 | Ballistic missiles, aircraft | LMT (RTX ground system) |
| SM-6 | $5,000,000 | Cruise missiles, ballistic terminal | RTX/Raytheon |
| SM-3 Block IIA | $12-15,000,000 | Ballistic missiles (exo-atmospheric) | RTX/Raytheon |

RTX retains an unchallengeable position in the high-end tier (SM-3, SM-6, Patriot) that cannot be replaced by $15K drones. But the Pentagon's procurement budget will increasingly allocate to the low-cost tier for the most common threats. RTX's Coyote Block 3 ($60K) competes in the middle tier but is 4x the cost of Merops.

### Munitions Depletion and Replenishment Timeline

| System | Pre-War Inventory | Consumed (est.) | Current Production | Framework Target | Years to Replenish |
|--------|-------------------|-----------------|--------------------|-----------------|--------------------|
| Tomahawk | ~3,100 ready | 400+ (72hrs) | ~190/yr | 1,000+/yr | 2-3 yrs at target rate |
| SM-6 | Classified | Heavy use | 125/yr (FY2026) | 500+/yr | 3-4 yrs at target rate |
| SM-3 | Classified | Moderate use | 76/yr (FY2026) | Accelerated | 3+ yrs |
| AMRAAM | Classified | Active use | ~600/yr | 1,900+/yr | 2-3 yrs at target rate |

The key insight: even at the framework agreement target production rates (which won't be reached until 2028-2029), replenishing wartime consumption takes 2-4 years. At CURRENT production rates, replenishment takes 4.5+ years for Tomahawk alone. This creates an extended revenue tail that flows through Raytheon segment P&L for the remainder of the decade.

## 9. Catalysts & Risks

### Upcoming Catalysts

| Catalyst | Expected Date | Potential Impact | Direction | Probability |
|----------|--------------|------------------|-----------|-------------|
| Q1 2026 earnings + guidance raise | Late April 2026 | Pre-war guide likely conservative; war-related orders should drive upward revision | Positive | HIGH |
| Supplemental budget approval | Q2-Q3 2026 | THE SWING VARIABLE. Even $50B is transformative for order books | Positive | MEDIUM |
| Golden Dome task orders | 2026-2027 | SM-3, SM-6, LTAMDS under $185B program. $13.4B FY2026 appropriated | Positive | HIGH |
| GTF Advantage production ramp | H2 2026 | Restores P&W competitive position | Positive | HIGH |
| European Patriot + AMRAAM orders | Ongoing 2026 | Additional NATO customers. $3.5B AMRAAM executing | Positive | VERY HIGH |
| Iran ceasefire → replenishment cycle | 2026-2027 | Ceasefire triggers massive munitions replenishment regardless of war outcome | Positive | MEDIUM |
| Trump escalates against RTX | 2026 | Contract delays, expanded restrictions | Negative | MEDIUM |
| Supplemental budget blocked | Q2-Q3 2026 | Removes primary earnings catalyst for FY2027-28 | Negative | MEDIUM |
| Broader market stagflation sell-off | Q2-Q3 2026 | Oil >$100, PCE rising, GDP slowing. Defense not immune to 15-20% S&P decline | Negative | MEDIUM-HIGH |
| Production ramp execution failure | 2027-2028 | 11x Tomahawk ramp unprecedented. Supply chain bottlenecks | Negative | LOW-MEDIUM |

### Key Risks

| Risk | Category | Probability | Impact | Timeframe | Mitigant |
|------|----------|-------------|--------|-----------|----------|
| Trump political targeting materializes | Political | 25% | High | Near-term | Legal challenges; Congress support for defense spending |
| Supplemental budget blocked/reduced | Political | 35% | High | Near-term | Framework agreements provide baseline regardless |
| GTF costs exceed $7B+ | Operational | 30% | High | Near-term | GTF Advantage, Hot Section Plus |
| Merops/drone disruption accelerates | Structural | 20% | Medium-High | Long-term | RTX retains high-end layer; Coyote Block 3 |
| Multiple compression to 23-24x | Valuation | 35% | High | Near-term | Fundamental earnings growth offsets |
| Production ramp failure at scale | Execution | 20% | High | Medium-term | $115M Redstone expansion complete; workforce ramp |

### Contrarian Checklist

**What could make us wrong (Bull Direction):**
1. RTX underperformance is a temporary anomaly — Q1 earnings show war-driven orders, stock catches up to peers with 30%+ upside
2. $200B+ supplemental passes in full — FY2027-28 estimates jump 20-30%, fair value → $220+
3. Golden Dome becomes dominant program of the decade — $185B = multi-decade RTX revenue stream
4. Framework agreements create annuity revenue — 7-year visibility at 2-4x production is unprecedented
5. GTF recovery executes perfectly — 3,500+ engine aftermarket = $6B+ annual high-margin revenue
6. European rearmament is generational — NATO at 4-5% GDP sustains growth for a decade

**What could make us wrong (Bear Direction):**
1. Market's refusal to re-rate RTX IS the tell — Trump risk materializes, RTX receives fewer contracts than peers
2. Merops and AI drones replace traditional interceptors faster than expected — Pentagon budget shifts
3. GTF recovery stalls — additional defects, costs past $10B, LEAP captures 85%+ share
4. Production ramp fails — 11x Tomahawk increase requires workforce and supply chains that don't exist
5. Iran war ends quickly — defense spending urgency evaporates, "sell the peace"
6. Stagflation recession drags defense stocks down with broader market

## 10. Position Recommendation

**Recommendation:** HOLD Existing Positions / ACCUMULATE Below $170

**Entry Range:** Below $170 (24.5x forward P/E, near re-rated peer median)
**Position Sizing:** 3-4% maximum portfolio weight (Conviction 2/3)
**Time Horizon:** 3-5 years (long-term R/R 4.15:1 Highly Favorable)
**Stop Loss:** $150 (bear case target)
**First Target:** $190 (base case fair value)
**Second Target:** $240 (long-term base case)

**Timing Considerations:**
- At $200.73, near-term R/R is 0.72:1 — unfavorable for new positions at current levels
- Accumulate below $170 where the forward P/E normalizes to the re-rated defense peer median with full optionality from supplemental, framework agreements, GTF recovery, and Golden Dome
- Existing holders should HOLD — the long-term R/R of 4.15:1 is Highly Favorable and improving
- The supplemental budget outcome (Q2-Q3 2026) is the single most important catalyst — if $100B+ passes, fair value moves to $210-220
- Q1 earnings (late April) will be the first test of whether war-related orders flow through guidance
- A break below $155 would suggest bear case materializing — reassess thesis

**v1.0 vs v2.0 Comparison:**

| Metric | v1.0 (Feb 16) | v2.0 (Mar 19) | Change |
|--------|:---:|:---:|--------|
| Rating | SLIGHT_OVERPRICED | FAIRLY_PRICED_HIGH | UPGRADE |
| Fair Value | $172 | $190 | +$18 (+10.5%) |
| Entry Price | Below $146 | Below $170 | +$24 |
| Near-Term R/R | 0.17:1 | 0.72:1 | Improved |
| Long-Term R/R | 1.70:1 | 4.15:1 | Dramatically improved |
| Conviction | 1/3 | 2/3 | Upgraded |
| Confidence | 6.8 (MEDIUM) | 7.2 (HIGH) | Upgraded |
| Position Size | 2-3% | 3-4% | Increased |

---

## Cross-Model Review

| Field | Value |
|-------|-------|
| Review Status | APPROVED |
| Reviewer | GPT-5.2 via Codex MCP |
| Iterations | 2 |
| Review Date | 2026-03-20 |
| Key Corrections | Iteration 1: Corrected 2 DCF sensitivity table cells — WACC 5.4%/TG 2.0% from $225 to $224, WACC 6.9%/TG 3.5% from $212 to $211. All other math verified correct. Iteration 2: APPROVED. |

---

*This report was generated by inv-AI's valuation framework using Claude (opus-4.6) for analysis. Cross-model review via GPT-5.2 is pending. This is NOT financial advice. See [inv-ai.com/terms](https://www.inv-ai.com/terms) for full disclaimer.*

*AI-readable version. For the styled human-readable report, see [RTX.html](/reports/RTX.html).*